NCT00552097View on ClinicalTrials.gov

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

June 1, 2002

Primary Completion Date

April 25, 2006

Study Completion Date

April 25, 2006

Conditions
AtherosclerosisHypercholesterolemiaHyperlipoproteinemia Type II
Interventions
DRUG

ezetimibe (plus simvastatin)

oral tablets; ezetimibe 10 mg (plus simvastatin 80 mg) once daily for 24 months

DRUG

placebo (plus simvastatin)

tablets; placebo to match ezetimibe 10 mg (plus simvastatin 80 mg) once daily for 24 months

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00552097 - Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) | Biotech Hunter | Biotech Hunter